Gene: CNDP2
Official Full Name: carnosine dipeptidase 2provided by HGNC
Gene Summary: CNDP2, also known as tissue carnosinase and peptidase A (EC 3.4.13.18), is a nonspecific dipeptidase rather than a selective carnosinase (Teufel et al., 2003 [PubMed 12473676]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18640 | CNDP2 Knockout cell line (HeLa) | Human | CNDP2 | 1:3~1:6 | Negative | Online Inquiry |
KO18641 | CNDP2 Knockout cell line (HCT 116) | Human | CNDP2 | 1:2~1:4 | Negative | Online Inquiry |
KO18642 | CNDP2 Knockout cell line (HEK293) | Human | CNDP2 | 1:3~1:6 | Negative | Online Inquiry |
KO18643 | CNDP2 Knockout cell line (A549) | Human | CNDP2 | 1:3~1:4 | Negative | Online Inquiry |
CNDP2 Gene Knockout Cell Lines are genetically engineered cellular models designed to specifically disrupt the expression of the CNDP2 gene, which plays a crucial role in various metabolic processes and neurological functions. These cell lines are created using advanced CRISPR/Cas9 technology, allowing precise editing of the genome, facilitating the study of gene function and the mechanisms of related pathological conditions.
The primary function of CNDP2 Gene Knockout Cell Lines is to provide a platform for investigating the physiological and pathological roles of the CNDP2 gene in cellular contexts. By eliminating the gene's expression, researchers can observe the resulting phenotypic changes and gain insights into pathways involved in neurodegeneration and metabolic disorders. Cell lines such as these are indispensable in elucidating the underlying mechanisms of diseases and can become pivotal in drug discovery and development processes.
The scientific importance of these cell lines extends to both fundamental research and clinical settings. They allow for the exploration of targeted therapies that could mitigate conditions arising from CNDP2 dysregulation. Researchers can utilize these knockout models to assess the efficacy of novel compounds or therapies aimed at restoring normal cellular functions or mitigating disease-like phenotypes.
When compared to alternatives such as standard wild-type cell lines or less specific knockout systems, CNDP2 Gene Knockout Cell Lines offer the unique advantage of specificity. This targeted approach minimizes off-target effects and enhances the reliability of experimental data, making findings more applicable to real-world scenarios.
For researchers and clinicians, the value of utilizing CNDP2 Gene Knockout Cell Lines lies in their ability to facilitate groundbreaking discoveries regarding gene function and its implications in diseases. This knowledge could lead to innovative treatments and therapeutic strategies, thus enhancing patient outcomes.
Our company prides itself on its expertise in developing high-quality, state-of-the-art biological products tailored for the advancement of scientific research. With a focus on precision and reliability, we are committed to supporting the scientific community in uncovering new insights that can transform health and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.